Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2011

Jun 9, 2011

32870_dirs_2011-06-09_e64b8592-176c-4df8-b085-8659c66c9d97.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2011-06-07

Reporting Person: Hauer Jerome M (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-06-07 Common Stock M 4800 $8.76 Acquired 12000 Direct
2011-06-07 Common Stock S 4800 $24.00 Disposed 7200 Direct
2011-06-07 Common Stock M 4800 $11.67 Acquired 12000 Direct
2011-06-07 Common Stock S 4800 $24.00 Disposed 7200 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-06-07 Employee Stock Options (right to buy) $8.76 M 4800 Disposed 2018-05-20 Common Stock (4800) Direct
2011-06-07 Employee Stock Options (right to buy) $11.67 M 4800 Disposed 2019-05-21 Common Stock (4800) Direct

Footnotes

F1: The option is fully vested.

F2: The option will vest with respect to the remaining 4,800 shares on May 17, 2012.